Iodine Supplementation in Pregnancy Cost Saving in U.K.

This article originally appeared here.
Share this content:
Iodine Supplementation in Pregnancy Cost Saving in U.K.
Iodine Supplementation in Pregnancy Cost Saving in U.K.

(HealthDay News) -- Iodine supplementation is potentially cost saving for pregnant women in the United Kingdom, according to a review published online Aug. 9 in The Lancet Diabetes & Endocrinology.

Mark Monahan, from the University of Birmingham in the United Kingdom, and colleagues conducted a systematic review to examine the cost-effectiveness of iodine supplementation versus no supplementation for pregnant women in a mildly to moderately iodine-deficient population. Clinical data relating to iodine deficiency in pregnant women and the effect on IQ in children aged 8 to 9 years were examined. Analyses were conducted from a health service perspective (direct health costs) and societal perspective (education costs and value of an IQ point). Eight articles were used to calculate the monetary value of an IQ point.

The researchers found that, based on earnings, the estimated discounted lifetime value of one additional IQ point was £3,297 for the offspring cohort. From a health service perspective and societal perspective, iodine supplementation was cost saving (saving £199 and £4,476, respectively, per pregnant woman), with a net gain of 1.22 IQ points in each analysis. Case results were robust to sensitivity analyses.

"Iodine supplementation for pregnant women in the United Kingdom is potentially cost saving," the authors write. "This finding also has implications for the 1.88 billion people in the 32 countries with iodine deficiency worldwide."

One author is a member of the U.K. Iodine Group.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin

More Evidence HPV Vaccine Protects Against Cervical Cancer

More Evidence HPV Vaccine Protects Against Cervical Cancer

Protection appears to occur even when only one or two of the recommended doses are given

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Study of millions of health records suggests an association

is free, fast, and customized just for you!

Already a member?

Sign In Now »